ConductScience.org, home

Disease · MONDO_0005550

infectious disease

6 sourcesdiseases-2026-09-18-0.1.0

Download JSON
Cite this record

ConductScience Library. infectious disease. Diseases, record MONDO_0005550. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0005550

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name
infectious disease
Open Targets
Open Targets ID
MONDO_0005550
Open Targets
Other names
communicable disease, disease by infectious agent, disorder due to infection, infection, infectious, infectious diseases and manifestations, infectious disorder, transmissible disease
Open Targets
Disease Ontology
DOID:0050117
Disease Ontology
MeSH
D003141
MeSH
NCI Thesaurus
C26726
NCI Thesaurus
Highest stage of its drugs
Approval, for 4 of its 27 drugs, from DailyMed and TTD
Open Targets

Drugs27

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

DrugChEMBL IDTypeOpen Targets' stageStage reported byReportsOf them trialsTrials shown hereSource
FLUOCINOLONE ACETONIDECHEMBL989Small moleculeApprovalDailyMed200Drugs and targets
AZOXIMER BROMIDECHEMBL4650378Small moleculeApprovalTTD100Drugs and targets
DEXTRANOMERCHEMBL2108201Small moleculeApprovalTTD100Drugs and targets
HYDROGEN PEROXIDECHEMBL71595Small moleculeApprovalTTD100Drugs and targets
CIPROFLOXACINCHEMBL8Small moleculePhase 3ClinicalTrials.gov211Drugs and targets
GLUCOSE OXIDASECHEMBL2108700EnzymePhase 3TTD100Drugs and targets
MYELOPEROXIDASECHEMBL2107858EnzymePhase 3TTD100Drugs and targets
RIBOFLAVINCHEMBL1534Small moleculePhase 3TTD100Drugs and targets
RIFAMYCINCHEMBL437765Small moleculePhase 3TTD100Drugs and targets
AURICLOSENECHEMBL1207907Small moleculePhase 2/3TTD100Drugs and targets

1 to 10 of 27

See all 27 drugs

Targets2

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

TargetProteinIts drugs that act on itMechanismsHighest stage of those drugsGene in GenesSource
CCR5C-C chemokine receptor type 51C-C chemokine receptor type 5 antagonistPhase 2https://conductscience.org/library/genes/1234Drugs and targets
NR3C1Glucocorticoid receptor1Glucocorticoid receptor agonistApprovalhttps://conductscience.org/library/genes/2908Drugs and targets

Trials5

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.

TrialTitlePhaseParticipantsResults first postedConditionsDrugsLinked bySource
NCT00761462BAY 0 9867 Cipro Pediatric Use Study (QUIP)Phase 31,0292009-04-14Infectious DiseasesCIPROFLOXACINIts record names the diseaseClinicalTrials.gov
NCT03020901the Clinical Trial of Teicoplanin for Injection100,000Infectious DiseaseTEICOPLANINIts record names the diseaseClinicalTrials.gov
NCT03643497Population Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious Diseases800Children;InfectionLINEZOLID, MEROPENEMIts record names the diseaseClinicalTrials.gov
NCT04937894Antibiotic Therapy for Infectious Diseases300Infectious DiseaseTIGECYCLINEIts record names the diseaseClinicalTrials.gov
NCT05775692Population Pharmacokinetics of Fluconazole in the Treatment of Neonatal Fungal Infectious Disease150Fluconazole, Infection, Newborn, PharmacokineticsFLUCONAZOLEIts record names the diseaseClinicalTrials.gov

Comparisons in its trials1

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrial
Ciprofloxacin vs Non-quinolone Antibiotic: serious adverse events25 of 4876 of 507994NCT00761462

Papers from its trials5

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMIDListed asTrials listing itSource
26755499RESULT1PubMed
26289222RESULT1PubMed
25155587RESULT1PubMed
36278190DERIVED1PubMed
32513801DERIVED1PubMed

Data dates

The date of each source this release read.

Open Targets
2026-09-18
Open Targets
Drug links and their checks, from Drugs and targets
2026-09-18
Drugs and targets
ClinicalTrials.gov, from Trials
2026-11-12
Trials
Comparisons, from Trial comparisons
2026-03-23
Trial comparisons
PubMed, for the checks
2026-11-06
PubMed
MeSH, for the checks
2026-11-10
MeSH

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0005550

GET https://conductscience.org/api/diseases/v1/MONDO_0005550/drugs?page=2